Swipe om te navigeren naar een ander artikel
In the management of diabetes and high-risk patients, timely treatment with scheduled medicines is critical to prevent severe infections and reduce the risk of lower extremity amputation. However, in Australia, few podiatrists have attained endorsement to prescribe. The aims of this study were to identify the costs associated with developing and implementing a podiatry prescribing mentoring program; and to compare the cost of this program against potential healthcare savings produced.
This was a cost-description analysis, involving the calculation of costs associated with the development and implementation of a mentoring program to train podiatrists to become endorsed prescribers. Costs were calculated using the Ingredients Method and examined from the perspective of a public health service provider, and the individual learner podiatrist. Breakeven analysis compared the cost of training a podiatry prescriber for endorsement against the potential benefit (savings) made by averting complications of an infected foot ulcer. A sensitivity analysis was conducted to allow for uncertainty in the results of an economic evaluation.
Total start-up cost for the podiatry prescriber mentoring program was $13, 251. The total cost to train one learner podiatrist was $30, 087, distributed between the hospital $17, 046 and the individual learner $13, 041. In the setting studied, a podiatry prescriber must avert 0.40 major amputations arising from an infected foot ulcer through prescribing to recover the cost of training. If in-kind training costs are included, total cost increases to $50, 654, and the breakeven point shifts to 0.68 major amputations averted.
The economic benefits (savings) created by an endorsed prescribing podiatrist over their career in a public health service are likely to outweigh the costs to train a podiatrist to attain endorsement. Further research is required to help understand the effectiveness of podiatry prescribing in reducing diabetic foot related complications and the potential economic impact of podiatry prescribers on this health condition.
Nissen L, Kyle G. Non-medical prescribing in Australia. Aust Prescr. 2010;33:166–7. CrossRef
Australian Health Ministers' Advisory Council: Guidance for National Boards: Applications to the Ministerial Council for approval of endorsements in relation to scheduled medicines under section 14 of the National Law. 2016.
Commonwealth of Australia: Portfolio Budget Statements 2010–11. Ageing Health and Education. Canberra: Commonwealth Copyright Administration; 2010.
Queensland Government: Health practitioner regulation National law act 2009 . Queensland; 2009.
Podiatry Board of Australia: Guidelines for endorsement for scheduled medicines . (Agency AHPR ed.; 2011.
Podiatry Board of Australia. Registrant data: reporting period 1st October 2017- 31st December 2017. Melbourne: Australian Health Practitioner Regulation Agency; 2017.
Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJ, Armstrong DG, Deery HG, Embil JM, Joseph WS, Karchmer AW, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012;54:e132–73. CrossRefPubMed
Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. 4th ed. United Kingdom: Oxford University Press; 2015.
Foo J, Ilic D, Rivers G, Evans DJR, Walsh K, Haines TP, Paynter S, Morgan P, Maloney S: Using cost-analyses to inform health professions education - the economic cost of pre-clinical failure. Med Teach. 2017:1–10.
Levin HM, McEwan PJ, Belfield C, Bowden AB, Shand R: Economic Evaluation in Education: Cost-Effectiveness and Benefit-Cost Analysis (3 ed.). SAGE publications; 2017.
Michailidis L, Williams C: Outcomes of diabetic foot wounds at peninsula health and Monash health: a retrospective audit. Peninsula Health and Monash Health Internal Reports; 2017.
National Weight Activity Unit (NWAU) Calculator, http://www.ihpa.gov.au/what-we-do/classifications], Accessed 1 Feb 2018.
National Weight Activity Unit Calculators 2016–2017. http://www.ihpa.gov.au/what-we-do/nwau-calculators-2016-17. Accessed 1 Feb 2018.
Health AGDo, The February 2017 Medicare Benefits Schedule. http://www.health.gov.au/internet/main/publishing.nsf/Content/di-medicare-item-groups. Accessed 27 Apr 2017.
Rivers G, Reeves S, Ilic D, Foo J, Walsh K, Maloney S. The Prato method: a guide to the application of economic evaluations in health professions education research. J Contin Educ Heal Prof. 2017;37:230–8.
Australian FairWork Commission: Victorian public health sector (Allied Health Professionals) Single Interest Enterprise Agreement 2017–2021; 2017.
Weeks G, George J, Maclure K, Stewart D. Non-medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care. Cochrane Database Syst Rev. 2016;11:CD011227. PubMed
Australian FairWork Commission: Victorian public health sector (Medical Scientists, Pharmacists and Psychologists) Single Interest Enterprise Agreement 2017–2021. 2017.
Independent, Hospital Pricing Authority: Teaching, Training and Research Costing Study. 2016.
Fair Work Commission: Victorian Public Health Sector (AMA VICTORIA)- Doctors in Training (Single Interest Employers) Enterprise Agreement 2013 (services HaW ed. Canberra: Commonwealth of Australia; 2013.
- Implementing a podiatry prescribing mentoring program in a public health service: a cost-description study
Anna G. Couch
Alicia M. James
Cylie M. Williams
- BioMed Central